FDA senior management perspectives

Clinical Trials

Volumn 2, Issue 4, 2005, Pages 373-378

  Woodcock, Janet ^a   Temple, Robert ^a   Midthun, Karen ^a   Schultz, Daniel ^a   Sundlof, Stephen ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RECOMBINANT SOMATOMEDIN C;

AMYOTROPHIC LATERAL SCLEROSIS; BAYES THEOREM; BREAST CANCER; CONFERENCE PAPER; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HORMONAL THERAPY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RADIODIAGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR;

EID: 24944447128     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1191/1740774505cn109oa     Document Type: Conference Paper

References (0)